Buyback — Emami Ltd
Established in the 70s, Emami Limited is one of the leading and fastest-growing personal and healthcare businesses in India. It is a flagship company of Emami Group and sells over 300+ products based on Ayurvedic formulations. Its product portfolio consists of a wide range of household brand names, including BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Mentho Plus Balm, Fast Relief, and Kesh King.
It is a Kolkata-based firm that operates 5 Manufacturing Units and 26 Depots in India. It operates 1 Overseas Manufacturing Unit in Bangladesh, 9 Overseas Subsidiaries, 7 Domestic Subsidiaries, and 2 associate companies, with a presence across 70+ countries.
What is your recommendation?
How would you rate this (1 to 5)?
| Buyback Meeting Date: | 17 Sept 2026 |
|---|---|
| Buyback Announcement Date: | 17 Sept 2026 |
| Buyback Record Date: | — |
| Last Date to Buy Shares: | — |
| Buyback Open Date: | 22 Sept 2026 |
| Buyback Close Date: | 29 Dec 2026 |
| Finalization of Buyback Acceptance: | — |
| Particulars | Details |
|---|---|
| Offer Amount: | ₹282 |
| Number of Shares: | 5936842 Equity Shares |
| Face Value: | ₹1 per equity share |
| Listing: | BSE, NSE |
| Buyback Type: | Tender Offer |
| Letter of Offer: | Click Here |
The investors, who have Emami Buyback shares in their Demat Account as of the Record Date, are eligible for the buyback scheme. Eligible Shareholders can participate in the Emami Buyback 2026 scheme as per the opening form by selling their shares. The payment will be given as per the Emami Buyback accepted shares by the company under the Emami Buyback scheme.
| Acceptance Ratio | Investment | Shares Buyback | Profit |
|---|---|---|---|
| 33% | ₹1,62,085 | 139 | ₹12,504 |
| 50% | ₹1,62,085 | 211 | ₹18,945 |
| 75% | ₹1,62,085 | 316 | ₹28,418 |
| 100% | ₹1,62,085 | 421 | ₹37,890 |
| Year | Revenue | Expense | PAT |
|---|---|---|---|
| 2026 | ₹3,864.63 | ₹3,004.35 | ₹779.32 |
| 2025 | ₹3,877.3 | ₹2,971.63 | ₹814.55 |
| 2024 | ₹3,624.89 | ₹2,824.44 | ₹727.86 |
Join the discussion
Please sign in to leave a comment or reply.